Oscar Health (NYSE:OSCR) Hits New 1-Year High – Should You Buy?
by Tristan Rich · The Markets DailyOscar Health, Inc. (NYSE:OSCR – Get Free Report)’s stock price hit a new 52-week high on Friday . The company traded as high as $34.23 and last traded at $33.6730, with a volume of 680219 shares changing hands. The stock had previously closed at $32.58.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the stock. Wells Fargo & Company upped their price target on shares of Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 13th. UBS Group raised their price objective on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a research report on Friday, August 7th. The Goldman Sachs Group reiterated a “neutral” rating and set a $30.00 target price on shares of Oscar Health in a research report on Tuesday, August 11th. Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. Finally, Barclays raised their price target on shares of Oscar Health from $35.00 to $39.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $26.22.
Check Out Our Latest Stock Analysis on Oscar Health
Oscar Health Stock Performance
The firm has a fifty day moving average of $30.58 and a 200-day moving average of $23.27. The firm has a market cap of $10.19 billion, a P/E ratio of 23.60, a PEG ratio of 0.65 and a beta of 2.37. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21.
Oscar Health (NYSE:OSCR – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The firm had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.73 billion. During the same period in the previous year, the business posted ($0.89) EPS. The company’s quarterly revenue was up 70.4% compared to the same quarter last year. Research analysts predict that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.
Insider Activity at Oscar Health
In related news, CAO Victoria Baltrus sold 958 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $30,129.10. Following the completion of the sale, the chief accounting officer directly owned 213,631 shares of the company’s stock, valued at $6,718,694.95. The trade was a 0.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Blackley sold 28,869 shares of the stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $907,930.05. Following the completion of the transaction, the chief financial officer owned 1,046,108 shares in the company, valued at $32,900,096.60. This represents a 2.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 4,322,257 shares of company stock worth $126,818,346 over the last 90 days. Insiders own 22.64% of the company’s stock.
Institutional Trading of Oscar Health
Several institutional investors and hedge funds have recently made changes to their positions in OSCR. Geode Capital Management LLC raised its position in shares of Oscar Health by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock worth $68,964,000 after purchasing an additional 116,430 shares during the period. BIT Capital GmbH grew its position in shares of Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after purchasing an additional 5,227,152 shares during the period. Simplify Asset Management Inc. bought a new stake in Oscar Health during the 4th quarter worth approximately $2,948,000. Fortis Group Advisors LLC increased its stake in Oscar Health by 82.9% during the 4th quarter. Fortis Group Advisors LLC now owns 189,857 shares of the company’s stock worth $2,724,000 after purchasing an additional 86,035 shares in the last quarter. Finally, Convergence Investment Partners LLC acquired a new stake in Oscar Health during the 1st quarter worth approximately $1,208,000. Institutional investors own 75.70% of the company’s stock.
Oscar Health Company Profile
Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.
Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.